Ocugen, Inc. Announces Completion of Dosing in Subjects
• Initiated Phase 2 clinical trial MALVERN, Pa., July 25, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) ...
Read more• Initiated Phase 2 clinical trial MALVERN, Pa., July 25, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) ...
Read moreCompany announcement – No. 35 / 2024 Zealand Pharma announces completion of an upsized equity offering of 8.35 million new ...
Read moreClinical testing of LP-310 expected to commence in mid-2024 Patient recruitment is underway for Phase 2a multicenter, dose-ranging study PITTSBURGH, ...
Read moreHOUSTON, TEXAS, May 31, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical ...
Read moreMIAMI, May 28, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a ...
Read moreCompletion of the additional equity investment of $140M by AstraZeneca, as previously announced on November 1 and 15, 2023 NEW ...
Read moreMIAMI, April 23, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a ...
Read moreTORONTO, April 10, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a ...
Read moreThis multinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare ...
Read moreTORONTO, April 04, 2024 (GLOBE NEWSWIRE) -- Further to its news release dated March 27, 2024, Quisitive Technology Solutions Inc. ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.